Literature DB >> 17352521

Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Sai-Hong Ignatius Ou and Randall F. Holcombe.

Sai-Hong Ignatius Ou1, Randall F Holcombe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352521     DOI: 10.2165/00003495-200767040-00011

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.

Authors:  Tomohiro Nishina; Ichinosuke Hyodo; Jiro Miyaike; Tomoki Inaba; Seiyuu Suzuki; Yasushi Shiratori
Journal:  Eur J Cancer       Date:  2004-07       Impact factor: 9.162

2.  A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.

Authors:  T R J Evans; G Pentheroudakis; J Paul; A McInnes; R Blackie; N Raby; R Morrison; G M Fullarton; M Soukop; A C McDonald
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.